Skip to content Skip to menu

Medicines policy guru wins top award

Wednesday, 24 October 2012

Media Release

The 2012 Pat Clear Award, the Australian medicines industry’s most prestigious award, has been won by Mendel Grobler, Director of Access and Public Affairs at Pfizer Australia.

The Award is presented annually to recognise an outstanding level of commitment by an individual, group or team for the benefit of the Australian medicines industry.

Mr Grobler received the award for his ongoing commitment over several decades to improving access to medicines for Australians and to the development of the industry.

Medicines Australia chief executive Dr Brendan Shaw said Mr Grobler was a highly deserving recipient of the award.

“Mendel’s remarkable career in the industry has spanned many years and is characterised by his passionate belief that Australians deserve the best medicines,” Dr Shaw said.

“He has worked tirelessly to that end over several decades by helping the industry and government better understand the policy environment that is so important to the industry and Australians’ access to medicines.

“Mendel has been a key contributor to the shaping of the policy environment for industry in Australia and an important adviser on major policy issues, such as PBS reforms and the Memorandum of Understanding with the Commonwealth.

“The fact that he has been more than happy to share his considerable intellect with his colleagues and the broader community for the greater good over the years is a credit to him and the Australian medicines industry.

“He has made a monumental contribution to the industry and I can think of no more worthy a winner of this prestigious award.”

The Pat Clear Award recognises outstanding levels of commitment by an individual, group or team for the benefit of the Australian medicines industry.

The award was established in 2002 to commemorate the substantial contribution Mr Clear made to the medicines industry in Australia during his 40-year career.


Contact Person:

Jamie Nicholson
Media Communications Manager
Phone: 0419 220 293


As COVID19 continues to spread, our thoughts go out to anyone who has been infected or impacted. We hope that you are taking the necessary precautions to keep safe and well, both at work and at home.

Medicines Australia continues to monitor the situation and take advice from the Department of Health and the World Health Organisation. We are focused on responding to the important short-term issues but are also ensuring we stay balanced and maintain a focus on the medium and long-term business for our industry along with the well-being of our people.

At Medicines Australia we have initiated the following to ensure we support containment measures to provide business continuity and the well-being of our staff.

  • All non-essential travel has been restricted or cancelled
  • All face-to-face meetings (with external stakeholders and members) have been changed to virtual meetings (where appropriate)
  • Staff have been provided with the latest official information on COVID-19 through a hot-link on the office intranet; this information is regularly monitored and updated
  • Flexible working arrangements are covered in our HR policy which will allow staff to work remotely, if or when required
  • Current IT infrastructure enables staff to work remotely and will be in use if any person needs to self-isolate
  • Visual reminders have been displayed around the office, providing information about best hygiene practices
  • Extra hand-sanitiser, tissues and cleaning products have been supplied to staff for their work spaces

Our latest information is located at